Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial

Clinical trial NCT06957093 · RECRUITING

Trial details

NCT number: NCT06957093
Sponsor: The First Hospital of Jilin University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2 (T2DM)Artificial Intelligence (AI)

Start date: 2025-06-15
Primary completion: 2026-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.